Although there is no clear evidence to suggest that osteocalcin is a good indicator of bone turnover and the mechanisms through which enterolactone may influence sclerostin concentration, enterodiol and enterolactone have pleiotropic effects on mechanisms involved in bone metabolism, and the results regarding BC’s influence on these enterolignans are promising but require further research. This evidence concerns the gene SOST and breast cancer.